The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports and issues briefs on topics important to population health.
September 2007 (Volume 85)
September 2007 | Karen Davis, Stuart Guterman
Medicare could become an innovative leader in using financial incentives to reward health care providers for providing excellent and efficient care throughout a patient’s illness. This article examines the variations in cost and quality in the provision of episodes of care and describes how a pay-for-performance payment system could be designed to narrow those variations and serve as a transition to a new Medicare payment policy that would align physicians’ incentives with improvements in both quality and efficiency. In particular, Medicare could stimulate greater efficiency by developing new payment methods that are neither pure fee-for-service nor pure capitation, beginning with a pay-for-performance payment system that rewards quality and efficiency and moving to a blended fee-for-service and case-rate system.
Author(s): Karen Davis; Stuart Guterman
Keywords: Medicare; efficiency; pay for performance; payment incentives; payment reform
Read on Wiley Online Library
Read on JSTOR
Volume 85, Issue 3 (pages 449–468)
Published in 2007
Public/Private Partnerships for Prescription Drug Coverage: Policy Formulation and Outcomes in Quebec’s Universal Drug Insurance Program, with Comparisons to the Medicare Prescription Drug Program in the United States
Markets and Medical Care: The United States, 1993–2005